4//SEC Filing
KERYX BIOPHARMACEUTICALS INC 4
Accession 0000899243-17-011614
CIK 0001114220operating
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:06 PM ET
Size
5.1 KB
Accession
0000899243-17-011614
Insider Transaction Report
Form 4
Madison Greg
See Remarks
Transactions
- Sale
Common Stock
2017-05-01$5.97/sh−4,122$24,608→ 378,678 total
Footnotes (2)
- [F1]Sale of a total of 4,122 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on April 28, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 248,154 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001114220
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:06 PM ET
- Size
- 5.1 KB